Purchase Order 75N95019P00514
Award Date
8/9/19
Potential Completion Date
9/6/19
Potential Value
$21K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Eurofins Discoverx Corporation
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $20,830.00 firm-fixed-price purchase order to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, for the provision of PATHHUNTER CHO-K1 DRD3 ARRESTIN CELL LINE and U2OS DRD3 ARRESTIN CELL LINE. This award is not associated with any set-aside program. Eurofins Discoverx Corporation is a leading provider of innovative cell-based assays...
This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, is for the provision of specialized cell-based assays, reagents, and services to support drug discovery and research. The $13,482.10 firm fixed-price purchase order was awarded by the Midwest Area of the U.S. Department of Health and Human Services, which includes agencies such as the National Institutes of Health (NIH). The contract is for the delivery of PathHunter HTR2A GPCR internalization...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for $301,894.16 in firm fixed-price services related to testing lead compounds for additional characterization and reagent development. The contract does not have a set-aside designation. Eurofins Discoverx Corporation is a provider of innovative cell-based...
This is a $19,386.28 firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency under the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for assaying services to support NIAAA's research activities, with a completion date of August 27, 2024. Eurofins Discoverx Corporation is a provider of cell-based assays, reagents, and services for drug...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order valued at approximately $1 million to Eurofins Discoverx Products, LLC for binding studies. The contract is to be performed in Fremont, California over a one year period ending August 2024. Eurofins Discoverx will provide binding assay services in support of NIH's efforts to facilitate the movement of scientific observations...
This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The $26,769.20 firm fixed-price purchase order is for the provision of PathHunter detection kit reagent, item #93-0001L, to support the HEAL (Helping to End Addiction Long-term) initiative's medicinal chemistry research to improve potency and selectivity of dopamine...
This federal contract award, valued at $17,895.60, was issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned, for-profit organization. The contract was awarded on a firm fixed-price basis without any set-aside designations. Eurofins Discoverx Corporation, which specializes in providing innovative cell-based assays, reagents, and services to support...
This is a $45,365 firm-fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The contract is for the analysis of three compounds in a panel of 50 customized cancer cell lines over a three-month period. The work aims to evaluate the effects of the compounds on cell proliferation, cell death, caspase activity, and...
The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $20,446 purchase order to Eurofins Discoverx Corporation of Fremont, California. Under the firm fixed price contract, Eurofins will provide GPCRMAX PANEL services to NIH NINDS from August 2023 through December 2023. As a leading provider of drug discovery services, Eurofins will support NINDS's work to understand, treat, and prevent disorders of the brain...
The federal contract award is for $300,609.00 and was granted to Eurofins Discovery Services North America, LLC, a foreign-owned, for-profit contract research organization. The award is a delivery order under a larger indefinite delivery vehicle (IDV) contract with the National Institute on Drug Abuse (NIDA), a part of the U.S. Department of Health and Human Services. The contract is for receptor profiling and predictive toxicology services, specifically receptor binding studies, safety...